CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of orthopedic conditions
3.4.1.2. Increase in demand for dental bone grafts
3.4.1.3. Advancements in bone grafts and substitutes
3.4.2. Restraints
3.4.2.1. High cost of surgeries
3.4.2.2. Ethical & regulatory issues related with bone grafting procedures
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Allografts
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Allografts Bone Grafts and Substitutes Market by Type
4.3. Bone grafts substitutes
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Bone grafts substitutes Bone Grafts and Substitutes Market by Type
4.4. Cell based matrices
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Spinal fusion
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Trauma
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Joint reconstruction
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Dental bone grafting
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Craniomaxillofacial
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Specialty clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: BONE GRAFTS AND SUBSTITUTES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End user
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End user
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End user
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End user
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End user
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End user
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End user
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End user
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End user
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End user
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End user
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End user
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Arthrex, Inc.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. Baxter International Inc.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Johnson & Johnson
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Medtronic plc
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. NuVasive, Inc.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Stryker Corporation
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Zimmer Biomet Holdings, Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Orthofix Holdings, Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Xtant Medical Holdings, Inc.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Integra LifeSciences
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
TABLE 01. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 02. BONE GRAFTS AND SUBSTITUTES MARKET FOR ALLOGRAFTS, BY REGION, 2021-2031 ($MILLION)
TABLE 03. GLOBAL ALLOGRAFTS BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 04. BONE GRAFTS AND SUBSTITUTES MARKET FOR BONE GRAFTS SUBSTITUTES, BY REGION, 2021-2031 ($MILLION)
TABLE 05. GLOBAL BONE GRAFTS SUBSTITUTES BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 06. BONE GRAFTS AND SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY REGION, 2021-2031 ($MILLION)
TABLE 07. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 08. BONE GRAFTS AND SUBSTITUTES MARKET FOR SPINAL FUSION, BY REGION, 2021-2031 ($MILLION)
TABLE 09. BONE GRAFTS AND SUBSTITUTES MARKET FOR TRAUMA, BY REGION, 2021-2031 ($MILLION)
TABLE 10. BONE GRAFTS AND SUBSTITUTES MARKET FOR JOINT RECONSTRUCTION, BY REGION, 2021-2031 ($MILLION)
TABLE 11. BONE GRAFTS AND SUBSTITUTES MARKET FOR DENTAL BONE GRAFTING, BY REGION, 2021-2031 ($MILLION)
TABLE 12. BONE GRAFTS AND SUBSTITUTES MARKET FOR CRANIOMAXILLOFACIAL, BY REGION, 2021-2031 ($MILLION)
TABLE 13. GLOBAL BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 14. BONE GRAFTS AND SUBSTITUTES MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. BONE GRAFTS AND SUBSTITUTES MARKET FOR SPECIALTY CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. BONE GRAFTS AND SUBSTITUTES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 17. BONE GRAFTS AND SUBSTITUTES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 20. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 21. NORTH AMERICA BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. U.S. BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 23. U.S. BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 24. U.S. BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 25. CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 26. CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 27. CANADA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 28. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 29. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 30. MEXICO BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 31. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 32. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 33. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 34. EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 35. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 36. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. GERMANY BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 39. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 40. FRANCE BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 41. UK BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 42. UK BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 43. UK BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 44. ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 45. ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 46. ITALY BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 47. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 48. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 49. SPAIN BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 50. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 51. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 52. REST OF EUROPE BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 53. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 54. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 55. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 56. ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 57. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 58. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 59. JAPAN BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 61. CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 62. CHINA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 64. INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 65. INDIA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 66. AUSTRALIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. AUSTRALIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 68. AUSTRALIA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 69. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 70. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 71. SOUTH KOREA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 74. REST OF ASIA-PACIFIC BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 75. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 76. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 77. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 78. LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 79. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 80. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 81. BRAZIL BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 82. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 83. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 84. SAUDI ARABIA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 86. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 87. SOUTH AFRICA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. REST OF LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 89. REST OF LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 90. REST OF LAMEA BONE GRAFTS AND SUBSTITUTES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 91. ARTHREX, INC.: KEY EXECUTIVES
TABLE 92. ARTHREX, INC.: COMPANY SNAPSHOT
TABLE 93. ARTHREX, INC.: PRODUCT SEGMENTS
TABLE 94. ARTHREX, INC.: PRODUCT PORTFOLIO
TABLE 95. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 96. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 97. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS
TABLE 98. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 99. BAXTER INTERNATIONAL INC.: KEY STRATERGIES
TABLE 100. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 101. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 102. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 103. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 104. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 105. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 106. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 107. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 108. MEDTRONIC PLC: KEY STRATERGIES
TABLE 109. NUVASIVE, INC.: KEY EXECUTIVES
TABLE 110. NUVASIVE, INC.: COMPANY SNAPSHOT
TABLE 111. NUVASIVE, INC.: PRODUCT SEGMENTS
TABLE 112. NUVASIVE, INC.: PRODUCT PORTFOLIO
TABLE 113. NUVASIVE, INC.: KEY STRATERGIES
TABLE 114. STRYKER CORPORATION: KEY EXECUTIVES
TABLE 115. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 116. STRYKER CORPORATION: PRODUCT SEGMENTS
TABLE 117. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 118. STRYKER CORPORATION: KEY STRATERGIES
TABLE 119. ZIMMER BIOMET HOLDINGS, INC.: KEY EXECUTIVES
TABLE 120. ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 121. ZIMMER BIOMET HOLDINGS, INC.: PRODUCT SEGMENTS
TABLE 122. ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 123. ZIMMER BIOMET HOLDINGS, INC.: KEY STRATERGIES
TABLE 124. ORTHOFIX HOLDINGS, INC.: KEY EXECUTIVES
TABLE 125. ORTHOFIX HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 126. ORTHOFIX HOLDINGS, INC.: PRODUCT SEGMENTS
TABLE 127. ORTHOFIX HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 128. ORTHOFIX HOLDINGS, INC.: KEY STRATERGIES
TABLE 129. XTANT MEDICAL HOLDINGS, INC.: KEY EXECUTIVES
TABLE 130. XTANT MEDICAL HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 131. XTANT MEDICAL HOLDINGS, INC.: PRODUCT SEGMENTS
TABLE 132. XTANT MEDICAL HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 133. XTANT MEDICAL HOLDINGS, INC.: KEY STRATERGIES
TABLE 134. INTEGRA LIFESCIENCES: KEY EXECUTIVES
TABLE 135. INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 136. INTEGRA LIFESCIENCES: PRODUCT SEGMENTS
TABLE 137. INTEGRA LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 138. INTEGRA LIFESCIENCES: KEY STRATERGIES
